According to Syndax Pharmaceuticals's latest financial reports the company's total assets are $0.61 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.61 B | 23.26% |
2022-12-31 | $0.49 B | 10.58% |
2021-12-31 | $0.44 B | 49.58% |
2020-12-31 | $0.30 B | 373.22% |
2019-12-31 | $63.52 M | -24.32% |
2018-12-31 | $83.93 M | -38.81% |
2017-12-31 | $0.13 B | 25.84% |
2016-12-31 | $0.10 B | 21.26% |
2015-12-31 | $89.9 M | 601.49% |
2014-12-31 | $12.81 M | -24.88% |
2013-12-31 | $17.06 M | 1029.87% |
2012-12-31 | $1.51 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.25 B | -58.88% | ๐บ๐ธ USA |